Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
Authors: Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City., Saltzstein DR; Urology San Antonio, San Antonio, Texas., Tutrone R; Chesapeake Urology, Towson, Maryland., Bossi A; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France., Brown BA; Myovant Sciences Inc, Brisbane, California., Lu S; Myovant Sciences Inc, Brisbane, California., Fallick M; Myovant Sciences Inc, Brisbane, California., Hanson S; Pfizer Inc, New York, New York., Tombal BF; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.
Source: JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38451492
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spratt+DE%22">Spratt DE</searchLink>; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22George+DJ%22">George DJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Shore+ND%22">Shore ND</searchLink>; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina.<br /><searchLink fieldCode="AU" term="%22Cookson+MS%22">Cookson MS</searchLink>; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City.<br /><searchLink fieldCode="AU" term="%22Saltzstein+DR%22">Saltzstein DR</searchLink>; Urology San Antonio, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Tutrone+R%22">Tutrone R</searchLink>; Chesapeake Urology, Towson, Maryland.<br /><searchLink fieldCode="AU" term="%22Bossi+A%22">Bossi A</searchLink>; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Brown+BA%22">Brown BA</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Fallick+M%22">Fallick M</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Hanson+S%22">Hanson S</searchLink>; Pfizer Inc, New York, New York.<br /><searchLink fieldCode="AU" term="%22Tombal+BF%22">Tombal BF</searchLink>; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38451492
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2023.7279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 594
    Titles:
      – TitleFull: Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spratt DE
      – PersonEntity:
          Name:
            NameFull: George DJ
      – PersonEntity:
          Name:
            NameFull: Shore ND
      – PersonEntity:
          Name:
            NameFull: Cookson MS
      – PersonEntity:
          Name:
            NameFull: Saltzstein DR
      – PersonEntity:
          Name:
            NameFull: Tutrone R
      – PersonEntity:
          Name:
            NameFull: Bossi A
      – PersonEntity:
          Name:
            NameFull: Brown BA
      – PersonEntity:
          Name:
            NameFull: Lu S
      – PersonEntity:
          Name:
            NameFull: Fallick M
      – PersonEntity:
          Name:
            NameFull: Hanson S
      – PersonEntity:
          Name:
            NameFull: Tombal BF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1